Guardant Health, Inc. (GH)

Guardant Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	828.85	739.02	563.95	449.54	373.65	286.73
Revenue Growth (YoY)	28.74%	31.04%	25.45%	20.31%	30.31%	33.75%
Cost of Revenue	308.01	289.8	227.05	156.33	122.91	92.54
Gross Profit	520.84	449.22	336.9	293.21	250.74	194.2
Selling, General & Admin	624.47	545.06	451.03	463.78	398.52	299.28
Research & Development	356.82	347.75	367.19	373.81	263.22	149.86
Operating Expenses	981.29	892.81	818.22	837.59	661.74	449.15
Operating Income	-460.45	-443.59	-481.33	-544.38	-411	-254.95
Interest Expense	-3.07	-2.58	-2.58	-2.58	-2.58	-4.77
Interest & Investment Income	41.58	53.69	35.37	6.07	3.93	10.17
Other Non Operating Income (Expenses)	8.35	1.8	2.52	-99.51	0.18	3.64
EBT Excluding Unusual Items	-413.58	-390.69	-446.02	-640.4	-409.47	-245.9
Gain (Loss) on Sale of Investments	1.14	-44.4	50.66	-13.05	-	-
Legal Settlements	-	-	-83.4	-	-	-
Other Unusual Items	-0.3	-	-	-	25	-
Pretax Income	-412.74	-435.09	-478.76	-653.45	-384.47	-245.9
Income Tax Expense	1.07	1.28	0.69	1.14	0.3	0.38
Earnings From Continuing Operations	-413.82	-436.37	-479.45	-654.59	-384.77	-246.28
Minority Interest in Earnings	-	-	-	-	-20.9	-7.5
Net Income	-413.82	-436.37	-479.45	-654.59	-405.67	-253.78
Net Income to Common	-413.82	-436.37	-479.45	-654.59	-405.67	-253.78
Shares Outstanding (Basic)	124	123	112	102	101	98
Shares Outstanding (Diluted)	124	123	112	102	101	98
Shares Change (YoY)	2.95%	9.61%	9.60%	0.85%	3.91%	7.62%
EPS (Basic)	-3.35	-3.56	-4.28	-6.41	-4.00	-2.60
EPS (Diluted)	-3.35	-3.56	-4.28	-6.41	-4.00	-2.60
Free Cash Flow	-271.73	-274.94	-345.46	-386.92	-284.05	-140.1
Free Cash Flow Per Share	-2.20	-2.24	-3.08	-3.79	-2.80	-1.44
Gross Margin	62.84%	60.79%	59.74%	65.22%	67.11%	67.73%
Operating Margin	-55.55%	-60.02%	-85.35%	-121.10%	-110.00%	-88.92%
Profit Margin	-49.93%	-59.05%	-85.02%	-145.61%	-108.57%	-88.51%
Free Cash Flow Margin	-32.78%	-37.20%	-61.26%	-86.07%	-76.02%	-48.86%
EBITDA	-419.12	-401.21	-438.44	-508.42	-388.73	-238.89
EBITDA Margin	-50.57%	-54.29%	-77.75%	-113.10%	-104.04%	-83.31%
D&A For EBITDA	41.33	42.39	42.88	35.96	22.27	16.07
EBIT	-460.45	-443.59	-481.33	-544.38	-411	-254.95
EBIT Margin	-55.55%	-60.02%	-85.35%	-121.10%	-110.00%	-88.92%
Revenue as Reported	739.02	739.02	563.95	449.54	373.65	286.73
Advertising Expenses	-	-	-	-	2.4	1.2

Updated Jul 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q